Amgen AMGN is one of the biggest biotech companies in the world, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health, nephrology and neur
The popular iShares Biotechnology ETF NASDAQ: IBB has formed a bullish consolidation in the upper portion of its 52-week range, hinting at a significant sector-wide breakout.
Amgen (AMGN) closed the most recent trading day at $283.04, moving -0.45% from the previous trading session.
Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Eli Lilly's stock has seen significant growth due to the success of its obesity drug, "Zepbound," but its high valuation and upcoming competition make it less attractive. Amgen, with its obesity candi
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

3 Biotech Stocks to Buy on the Dip: March 2024

01:07pm, Wednesday, 27'th Mar 2024
One of the best dip-buying opportunities in biotech stocks to buy was in Viking Therapeutics (NASDAQ: VKTX ). After hitting a high of $99.41, VKTX dipped back to about $60.30.

7 Dow Stocks to Buy on the Dip: March 2024

06:00am, Wednesday, 27'th Mar 2024
The Dow Jones Industrial Average recently made new all-time highs, reaching a peak of 39,889. This has set off great excitement, with 40,000 seeming imminent and the possibility of Dow 50,000 starting

Wall Street Awaits Consumer Confidence Data

11:26am, Tuesday, 26'th Mar 2024
U.S. stock markets saw a pullback on Monday to start a holiday-shortened week. However, Wall Street is likely to record the fifth consecutive winning month despite volatility.
Wall Street is likely to record the fifth consecutive winning month despite volatility.
In the most recent trading session, Amgen (AMGN) closed at $280.82, indicating a +1.68% shift from the previous trading day.
Warren Buffett stocks can teach you a thing or two about investing. Warren Buffett's annual shareholders letter to Berkshire Hathaway (NYSE: BRK-A )(NYSE: BRK-B ) investors outlines what he's done the
Amgen is testing a monthly injection that works differently and appears to help patients maintain their weight loss even after they stop taking it.
When it comes to risk vs. reward in the stock market, the biotech sector has one of the highest potential payoffs.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE